CALGARY, Sept. 21, 2018 /CNW/ – High Tide Ventures Inc. (“High Tide” or the “Company”) today announced that it congratulates FSD Pharma Inc. (CSE:HUGE) (“FSD Pharma”) for achieving a $1 Billion market capitalization and its other recent successes. The Company would like to commend FSD Pharma on reaching such a significant valuation milestone in the Canadian cannabis market, which only a small number of other companies have been able to achieve. Further, High Tide would also like to acknowledge the significance of FSD Pharma’s recent receipt of $7.5 Million from Auxly Cannabis Group Inc. (TSX.V:XLY) (“Auxly”), at a premium to its recent market share price, to further fund construction of its 220,000 square foot cultivation facility in Cobourg, Ontario.
High Tide’s relationship with FSD Pharma was formalized after it participated in the Company’s private placement that closed on May 2, 2018. Subsequently, High Tide and FSD Pharma entered into a non-binding memorandum of understanding to supply the Saskatchewan market with cannabis products on a wholesale basis, which was announced on July 30, 2018. “We are extremely proud of our partnership with FSD Pharma and are working together to achieve mutually beneficial results”, said Raj Grover, President & Chief Executive Officer of High Tide. Anthony Durkacz, Executive Vice President of FSD Pharma, added, “We greatly appreciate High Tide’s support and look forward to exploring more business opportunities together as both of our companies continue to grow, along with the Canadian cannabis industry.”
Since commencing trading on the Canadian Securities Exchange (the “CSE”) on May 29, 2018, FSD Pharma has continued to set various new records for volumes traded. This level of liquidity has helped bring credibility and comfort not only to itself as an issuer, but also to the broader market. As High Tide prepares to go public on the CSE, it appreciates the strategic guidance and positive examples set by FSD Pharma in relation to the capital markets.
About High Tide Ventures Inc.
High Tide is a privately-held, Alberta-based, retail-focused cannabis corporation. It is among the most vertically-integrated companies in the Canadian cannabis market, with portfolio entities including RGR Canada, Smoker’s Corner, Famous Brandz, Canna Cabana and the majority of KushBar. High Tide’s strategy as a parent company is to extend and strengthen its retail-focused integrated value chain, while providing a complete customer experience and maximizing shareholder value.
Representing the core of High Tide’s business, RGR Canada is a high-quality and innovative designer, manufacturer and distributor of cannabis accessories. Founded in 2009 and approved by the Canadian Franchise Association, Smoker’s Corner is Canada’s largest counter-culture chain with 19 current locations. Famous Brandz is a dominant manufacturer of licensed lifestyle accessories, through partnerships with celebrities and entertainment companies like Snoop Dogg and Paramount Pictures, respectively, which are sold to wholesalers and retailers around the world. Upon the legalization of recreational cannabis across Canada on October 17, 2018, Canna Cabana is positioned to become a sizeable retail brand through a modern concept with a sophisticated yet playful customer experience, while KushBar is a retail concept that will also be focused on the valued Canadian cannabis consumer.
For more information about High Tide Ventures Inc., visit www.hightideventures.com
About FSD Pharma Inc. (CSE:HUGE)
FSD Pharma owns, through its wholly-owned subsidiary FV Pharma Inc., a license to produce marijuana under the Access to Cannabis for Medical Purposes Regulations (ACMPR) which was originally granted on October 13, 2017. Headquartered at the former Kraft plant in Cobourg, Ontario, approximately an hour’s drive from Toronto, FSD Pharma’s management’s mission is to transform the facility into the largest hydroponic indoor cannabis facility in the world. FSD Pharma intends to target all legal aspects of the cannabis industry, including cultivation, processing, manufacturing, extracts and research and development. Please visit www.fsdpharma.com for more information.
About FV Pharma
FV Pharma is a licensed producer under the Access to Cannabis for Medical Purposes Regulations (ACMPR), having received its cultivation license on October 13, 2017. Headquartered at the former Kraft plant in Cobourg, Ontario, approximately an hour’s drive from Toronto, FV Pharma management’s mission is to transform the facility into the largest hydroponic indoor cannabis facility in the world. FV Pharma intends to target all legal aspects of the cannabis industry, including cultivation, processing, manufacturing, extracts and research and development.
About Auxly Cannabis Group Inc. (TSX.V: XLY)
Auxly Cannabis Group is a collective of entrepreneurs with a passion for the cannabis industry past, present and future. Our mandate is to facilitate growth for our partners by providing them with financial support and sharing our collective industry experience. Our partners all have different visions, voices and brand values, and all share a common goal—to build a world-class industry based on ethics, diversity, quality and innovation. Please visit www.auxly.com for more information.
Certain statements in this news release are forward-looking information or forward-looking statements. Such information and statements, referred to herein as “forward-looking statements” are made as of the date of this news release or as of the date of the effective date of information described in this news release, as applicable. Forward-looking statements relate to future events or future performance and reflect current estimates, predictions, expectations or beliefs regarding future events. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (generally, forward-looking statements can be identified by use of words such as “outlook”, “expects”, “intend”, “forecasts”, “anticipates”, “plans”, “projects”, “estimates”, “envisages, “assumes”, “needs”, “strategy”, “goals”, “objectives”, or variations thereof, or stating that certain actions, events or results “may”, “can”, “could”, “would”, “might”, or “will” be taken, occur or be achieved, or the negative of any of these terms or similar expressions, and other similar terminology) are not statements of historical fact and may be forward-looking statements.
Such forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to the ability of High Tide to execute on its business plan and that High Tide will receive one or multiple licenses from Alberta Gaming, Liquor & Cannabis, British Columbia’s Liquor Distribution Branch or the Saskatchewan Liquor and Gaming Authority permitting it to carry on its Canna Cabana and KushBar businesses. High Tide considers these assumptions to be reasonable in the circumstances, given the time periods for such outlook. However, there can be no assurance that any one or more of the government, industry, market, operational or financial targets as set out herein will be achieved. Inherent in the forward-looking statements are known and unknown risks, uncertainties and other factors that could cause actual results, performance or achievements, or industry results, to differ materially from any results, performance or achievements expressed or implied by such forward-looking statements.
The forward‐looking statements contained herein is current as of the date of this news release. Except as required by law, High Tide does not have any obligation to advise any person if it becomes aware of any inaccuracy in or omission from any forward-looking statement, nor does it intend, or assume any obligation, to update or revise these forward-looking statements to reflect new events or circumstances. Any and all forward-looking statements included in this news release are expressly qualified by this cautionary statement, and except as otherwise indicated, are made as of the date of this news release.